Vectorite Biomedical Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 24.544 million compared to TWD 26.541 million a year ago. Operating loss was TWD 60.923 million compared to TWD 82.573 million a year ago. Net loss was TWD 68.171 million compared to TWD 90.269 million a year ago. Basic loss per share was TWD 1.42 compared to TWD 2.14 a year ago.